LABS — Income Statement (Laba Rugi)
Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — LABS PT UBC Medical Indonesia Tbk
| Dalam Jutaan IDR | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Total Pendapatan | 40,022 | 199,295 | 135,436 | 86,697 | 33,463 | 147,637 | 106,429 | 64,534 |
| Total Beban Pokok Penjualan | (21,499) | (119,578) | (80,908) | (53,277) | (18,143) | (90,209) | (62,417) | (36,924) |
| Laba Kotor | 18,522 | 79,717 | 54,528 | 33,420 | 15,320 | 57,429 | 44,013 | 27,611 |
| Total Beban Usaha | (17,679) | (58,236) | (41,642) | (26,500) | (12,226) | (47,675) | (37,098) | (24,336) |
| Laba Usaha | 844 | 21,481 | 12,886 | 6,920 | 3,094 | 9,753 | 6,914 | 3,275 |
| Penghasilan/Beban Lain-Lain | (434) | (3,959) | (923) | 137 | (1,245) | (4,464) | (1,301) | (1,507) |
| Laba Sebelum Pajak | 410 | 17,522 | 11,963 | 7,057 | 1,849 | 5,290 | 5,614 | 1,768 |
| Beban Pajak Penghasilan | - | (4,015) | - | - | - | (2,337) | - | - |
| Laba Bersih Dari Operasi Yang Dilanjutkan | 410 | 13,507 | 11,963 | 7,057 | 1,849 | 2,952 | 5,614 | 1,768 |
| Hak Minoritas | - | - | - | - | - | - | - | - |
| Penyesuaian Proforma | - | - | - | - | - | - | - | - |
| Laba Bersih Tahun Berjalan | 410 | 13,507 | 11,963 | 7,057 | 1,849 | 2,952 | 5,614 | 1,768 |
| Pendapatan Komprehensif Lain | - | 203 | - | - | - | 122 | - | - |
| Jumlah Laba Komprehensif | 410 | 13,710 | 11,963 | 7,057 | 1,849 | 3,074 | 5,614 | 1,768 |
| Laba Bersih Yang Dapat Diatribusikan | 410 | 13,507 | 11,963 | 7,057 | 1,849 | 2,952 | 5,614 | 1,768 |
| Laba Komprehensif Yang Dapat Diatribusikan | 410 | 13,710 | 11,963 | 7,057 | 1,849 | 3,074 | 5,614 | 1,768 |
Key Ratios — LABS
| Rasio | Q1 2026 ×4 | Q4 2025 | Q3 2025 ×1⅓ | Q2 2025 ×2 | Q1 2025 ×4 | Q4 2024 | Q3 2024 ×1⅓ | Q2 2024 ×2 |
|---|---|---|---|---|---|---|---|---|
| Profitabilitas | ||||||||
| Gross Margin (%) | 46.28% | 40.00% | 40.26% | 38.55% | 45.78% | 38.90% | 41.35% | 42.78% |
| Operating Margin (%) | 2.11% | 10.78% | 9.51% | 7.98% | 9.25% | 6.61% | 6.50% | 5.07% |
| Net Margin (%) | 1.02% | 6.78% | 8.83% | 8.14% | 5.52% | 2.00% | 5.27% | 2.74% |
| ROE (%) | 1.07% | 8.86% | 10.58% | 9.68% | 5.26% | 2.13% | 5.29% | 5.10% |
| ROA (%) | 0.75% | 5.92% | 7.33% | 6.75% | 3.49% | 1.45% | 3.15% | 2.18% |
| Per Lembar Saham | ||||||||
| EPS (Rp) | 0,41 | 3,42 | 4,04 | 3,57 | 1,87 | 0,75 | 1,89 | 0,90 |
| BVPS (Rp) | 38,70 | 38,60 | 38,16 | 36,91 | 35,60 | 35,13 | 35,85 | 17,54 |
| Valuasi | ||||||||
| PER (x) | 358.54x | 42.98x | 36.39x | 41.18x | 78.61x | 196.00x | 77.78x | 163.33x |
| PBV (x) | 3.80x | 3.81x | 3.85x | 3.98x | 4.13x | 4.18x | 4.10x | 8.38x |
| Struktur Modal | ||||||||
| DER (x) | 0.43x | 0.50x | 0.44x | 0.43x | 0.51x | 0.47x | 0.68x | 1.34x |